Order Article Reprints

Ruznic E, Klebermass M, Zellinger B, Langer B, Grambozov B, Purevdorj A, Karner J, Gruber G, Stana M, Minasch D, et al. Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR). Journal of Clinical Medicine. 2025; 14(3):945. https://doi.org/10.3390/jcm14030945

Ruznic, Elvis, Marisa Klebermass, Barbara Zellinger, Brigitte Langer, Brane Grambozov, Ayurzana Purevdorj, Josef Karner, Georg Gruber, Markus Stana, Danijela Minasch, and et al. 2025. "Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)" Journal of Clinical Medicine 14, no. 3: 945. https://doi.org/10.3390/jcm14030945

Ruznic, E., Klebermass, M., Zellinger, B., Langer, B., Grambozov, B., Purevdorj, A., Karner, J., Gruber, G., Stana, M., Minasch, D., Kirchhammer, K., Steffal, C., Stranzl, H., Moosbrugger, R., Feurstein, P., Dieckmann, K., & Zehentmayr, F., on behalf of the ALLSTAR Group. (2025). Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR). Journal of Clinical Medicine, 14(3), 945. https://doi.org/10.3390/jcm14030945